Distribution of GlaxoSmithKline diabetes drug Avandia has been suspended for six months in Saudi Arabia, as links to adverse cardiovascular effects are studied in more detail. The Saudi Food and Drug Authority made the decision, and called for the pharmaceutical company to provide further evidence before permanent removal.
Diabetes is a major problem in Saudi Arabia, particularly in the more developed areas such as Riyadh. According to the director of the SFDA national drug and poison center, Abdullah Al-Humaidan: "The SFDA Committee for Medicinal Products Registration has given the company six months to provide evidence as to why the drug should not be permanently removed from the Saudi market."
He went on to further outline concerns about the base chemical in Avandia, rosiglitazone. An is an oral diabetes medicine to help people with type 2 diabetes control their blood sugar levels . As many as 27 per cent of Saudis suffer from diabetes, with the disease spreading at an alarming rate.
Diabetes drug distribution suspended in Saudi Arabia
Tue, 23 Mar 2010
Recommended links
Diabetes forumDiabetes myLifestyle
Diabetes symptoms
Diabetes donate
Diabetes pensions and annuities
Diabetes.co.uk ID alert wristband
The Diet Plate to help control diabetes
Diabetes management system approved by Food and Drug Administration
Food and Drug Administration call for more information on Amylin diabetes drug
Supporters of diabetes drug had financial ties to pharmaceutical company
Diabetes injection Byetta LAR faces Food and Drug Administration decision
GlaxoSmithKline defends diabetes drug Avandia
Patient concern over diabetes drug Avandia
Food and Drug Administration say diabetes patients should not stop taking Avandia
Popular Cholesterol drugs increase diabetes risk
Smell of fish may put patients off diabetes drug
24 hour Diabetes drug Victoza approved for National Health Service use
Diabetes drug could cut body mass index
Weight loss drug alli could reduce dangerous diabetes fat
Type 2 diabetes drug gets Food and Drug Administration approval
Lexicon diabetes drug hits mid-stage trial
Diabetes drug clinical trials underway
Death risk increased 60 per cent by diabetes drug
Roche diabetes drug hits targets
New type 1 diabetes drug
Diabetes drug warning has doctors on alert
Label change for type 2 diabetes drug
Diabetes prevention using diet, not drugs
Diabetes drug better for weight loss
Diabetes drug may have pancreatitis risk
Denial over diabetes drug link
Heart risk not alleviated by diabetes drugs
Join us